Zydus Lifesciences’ Desidustat Receives Approval from China’s NMPA
Zydus Lifesciences has received approval from China’s National Medical Products Administration (NMPA) for Desidustat tablets, indicated for the treatment of […]
ORAL-THERAPY
Zydus Lifesciences Launches Rexigo, a Game-Changer Oral Therapy for Advanced Prostate Cancer Treatment in India
Zydus Lifesciences, a prominent player in the global healthcare sector, has unveiled Rexigo, the first-ever oral once-a-day therapy designed for […]
